T1	PROC 44 75	Estudio maestro de continuación
T2	PROC 1023 1030;1066 1071	estudio ciego
#1	AnnotatorNotes T2	C2347038; Blinded Clinical Study; Research Activity
T3	CHEM 145 153	Olaparib
#2	AnnotatorNotes T3	C2316164; olaparib; Organic Chemical · Pharmacologic Substance
T4	PROC 175 206	Estudio maestro de continuación
T5	CHEM 276 284	Olaparib
#3	AnnotatorNotes T5	C2316164; olaparib; Organic Chemical · Pharmacologic Substance
T6	PROC 356 380	continuar el tratamiento
#4	AnnotatorNotes T6	C2091305; continue current medication; Therapeutic or Preventive Procedure
T7	DISO 403 419	Cáncer de ovario
#5	AnnotatorNotes T7	C1140680; Malignant neoplasm of ovary; Neoplastic Process
T8	DISO 459 475	cáncer de ovario
#6	AnnotatorNotes T8	C1140680; Malignant neoplasm of ovary; Neoplastic Process
T9	PROC 676 704	continuación del tratamiento
#7	AnnotatorNotes T9	C2091305; continue current medication; Therapeutic or Preventive Procedure
T10	PROC 548 572	Consentimiento Informado
#8	AnnotatorNotes T10	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T11	CHEM 944 952	olaparib
#9	AnnotatorNotes T11	C2316164; olaparib; Organic Chemical · Pharmacologic Substance
T12	PROC 1007 1018	tratamiento
#10	AnnotatorNotes T12	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T13	DISO 480 488	mutación
T14	DISO 1142 1151	Toxicidad
#11	AnnotatorNotes T14	C0600688; Toxic effect; Injury or Poisoning
T15	PROC 1216 1244	interrupción del tratamiento
#12	AnnotatorNotes T15	C0850893; stop medication; Therapeutic or Preventive Procedure
T16	PROC 1301 1312	tratamiento
#13	AnnotatorNotes T16	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T17	CHEM 1339 1350	medicamento
#14	AnnotatorNotes T17	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T18	DISO 1565 1574	toxicidad
#15	AnnotatorNotes T18	C0600688; Toxic effect; Injury or Poisoning
T19	DISO 1577 1604	progresión de la enfermedad
#16	AnnotatorNotes T19	C0242656; Disease Progression; Pathologic Function
T20	CHEM 1653 1660	fármaco
#17	AnnotatorNotes T20	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T21	ANAT 413 419	ovario
#18	AnnotatorNotes T21	C0029939; Ovary; Body Part, Organ, or Organ Component | C1278992; Entire ovary; Body Part, Organ, or Organ Component
T22	ANAT 469 475	ovario
#19	AnnotatorNotes T22	C0029939; Ovary; Body Part, Organ, or Organ Component | C1278992; Entire ovary; Body Part, Organ, or Organ Component
T23	CHEM 709 717	olaparib
#20	AnnotatorNotes T23	C2316164; olaparib; Organic Chemical · Pharmacologic Substance
T24	Date 12 16	2019
T26	LIVB 79 88	pacientes
#21	AnnotatorNotes T26	C0030705; Patients; Patient or Disabled Group
T28	LIVB 210 219	pacientes
#22	AnnotatorNotes T28	C0030705; Patients; Patient or Disabled Group
T29	LIVB 294 306	investigador
#23	AnnotatorNotes T29	C0035173; Research Personnel; Professional or Occupational Group
T30	LIVB 445 454	Pacientes
#24	AnnotatorNotes T30	C0030705; Patients; Patient or Disabled Group
T31	GENE 492 496	BRCA
#25	AnnotatorNotes T31	C0596223; brca gene; Gene or Genome
T32	LIVB 528 536	paciente
#26	AnnotatorNotes T32	C0030705; Patients; Patient or Disabled Group
T33	LIVB 610 622	investigador
#27	AnnotatorNotes T33	C0035173; Research Personnel; Professional or Occupational Group
T34	LIVB 627 635	paciente
#28	AnnotatorNotes T34	C0030705; Patients; Patient or Disabled Group
T35	LIVB 861 869	paciente
#29	AnnotatorNotes T35	C0030705; Patients; Patient or Disabled Group
T37	Date 1178 1186	en curso
T39	Date 1313 1324	actualmente
T40	Date 1395 1406	actualmente
T43	LIVB 1705 1713	paciente
#30	AnnotatorNotes T43	C0030705; Patients; Patient or Disabled Group
T25	PROC 1023 1030;1056 1063	estudio abierto
#31	AnnotatorNotes T25	C1709323; Open Label Study; Research Activity
T27	PROC 113 133	estudio en oncología
#32	AnnotatorNotes T27	C1516640; Cancer Treatment Trial; Research Activity (?)
T36	PROC 244 264	estudio en oncología
#33	AnnotatorNotes T36	C1516640; Cancer Treatment Trial; Research Activity (?)
T41	PROC 894 914	estudio en oncología
#34	AnnotatorNotes T41	C1516640; Cancer Treatment Trial; Research Activity (?)
T42	PROC 1423 1443	investigación médica
#35	AnnotatorNotes T42	C0079816; Medical Research activity; Research Activity
A1	Status T27 History_of
A2	Status T36 History_of
A3	Status T23 History_of
A5	Status T11 History_of
A6	Assertion T17 Contraindicated
A4	Status T9 History_of
A7	Status T25 History_of
A8	Status T2 History_of
#36	AnnotatorNotes T13	C1705285; Mutation Abnormality; Cell or Molecular Dysfunction
#37	AnnotatorNotes T39	C0521116; Current (present time); Temporal Concept 
#38	AnnotatorNotes T40	C0521116; Current (present time); Temporal Concept 
T38	Observation 1191 1199	resuelta
A9	Assertion T38 Negated
#39	AnnotatorNotes T38	C1709863; Recovered or Resolved; Finding
T44	Neg_cue 1188 1190	no
T45	Neg_cue 1687 1690	sin
T46	CONC 1691 1696	coste
A10	Assertion T46 Negated
#40	AnnotatorNotes T46	C0220812; Cost aspects; Functional Concept
T47	Quantifier_or_Qualifier 1464 1474	compatible
A11	Assertion T47 Negated
T48	Neg_cue 1448 1450	no
R1	Has_Quantifier_or_Qualifier Arg1:T42 Arg2:T47	
R2	Negation Arg1:T48 Arg2:T47	
R3	Negation Arg1:T45 Arg2:T46	
R4	Negation Arg1:T44 Arg2:T38	
R5	Experiences Arg1:T26 Arg2:T3	
R6	Experiences Arg1:T28 Arg2:T5	
T49	Observation 327 352	beneficiarse clínicamente
R7	Causes Arg1:T6 Arg2:T49	
R8	Used_for Arg1:T5 Arg2:T6	
R9	Experiences Arg1:T28 Arg2:T49	
R10	Location_of Arg1:T21 Arg2:T7	
R11	Location_of Arg1:T22 Arg2:T8	
R12	Experiences Arg1:T30 Arg2:T8	
R13	Location_of Arg1:T31 Arg2:T13	
R14	Overlap Arg1:T8 Arg2:T13	
R15	Experiences Arg1:T30 Arg2:T13	
T50	Observation 644 669	beneficiando clínicamente
R16	Experiences Arg1:T34 Arg2:T50	
R17	Experiences Arg1:T34 Arg2:T9	
R18	Causes Arg1:T9 Arg2:T50	
R19	Used_for Arg1:T23 Arg2:T9	
R20	Experiences Arg1:T35 Arg2:T11	
T51	Observation 980 997	beneficio clínico
R21	Causes Arg1:T11 Arg2:T51	
R22	Experiences Arg1:T35 Arg2:T51	
R23	Causes Arg1:T12 Arg2:T51	
R24	Used_for Arg1:T11 Arg2:T12	
R25	Experiences Arg1:T35 Arg2:T12	
T52	Quantifier_or_Qualifier 1155 1173	Grado 3 o superior
R26	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T52	
R27	Overlap Arg1:T14 Arg2:T37	
R28	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T38	
R29	Before Arg1:T14 Arg2:T15	
R30	Used_for Arg1:T17 Arg2:T16	
R31	Overlap Arg1:T17 Arg2:T39	
T53	Observation 1382 1394;1407 1443	Participando en otro tipo de investigación médica
R32	Overlap Arg1:T53 Arg2:T40	
R33	Overlap Arg1:T42 Arg2:T40	
T54	Observation 1522 1551	Salida permanente del estudio
#41	AnnotatorNotes T54	C0422727; Patient withdrawn from trial; Finding
R34	Causes Arg1:T18 Arg2:T54	
R35	Causes Arg1:T19 Arg2:T54	
R36	Experiences Arg1:T43 Arg2:T20	
#42	AnnotatorNotes T47	C1524057; Compatible; Qualitative Concept
#43	AnnotatorNotes T37	C0521116; Current (present time); Temporal Concept
#44	AnnotatorNotes T49	C4049461; Unexpected beneficial therapeutic response; Finding (?)
#45	AnnotatorNotes T50	C4049461; Unexpected beneficial therapeutic response; Finding (?)
#46	AnnotatorNotes T51	C4049461; Unexpected beneficial therapeutic response; Finding (?)
A12	Experiencer T43 Patient
A13	Experiencer T35 Patient
A14	Experiencer T34 Patient
A15	Experiencer T33 Other
A16	Experiencer T32 Patient
A17	Experiencer T30 Patient
A18	Experiencer T29 Other
A19	Experiencer T26 Patient
A20	Experiencer T28 Patient
